TheProfitWatch

TRAW - Traws Pharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.2 0.11 (5.0%) 0.0 (0.0%) 0.0 (0.0%) 0.0 (0.22%) --- 0.11 (5.0%) --- ---

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.11
Diluted EPS:
-0.11
Basic P/E:
-21.0
Diluted P/E:
-21.0
RSI(14) 1m:
50.0
VWAP:
2.31
RVol:

Events

Period Kind Movement Occurred At

Related News